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Mechanisms  associated  with  the  progression  of  non-alcoholic  fatty  liver  disease  (NAFLD)  remain  unclear.
We attempted  to identify  the  pattern  of altered  gene  expression  at  different  time  points  in a high fat  diet
(HFD)-induced  NAFLD  mouse  model.  The  early  up-regulated  genes  are  mainly  involved  in the  innate
immune  responses,  while  the late up-regulated  genes  represent  the  inﬂammation  processes.  Although
recent  studies  have  shown  that  microRNAs  play  important  roles  in hepatic  metabolic  functions,  the
pivotal  role  of  microRNAs  in the progression  of NAFLD  is not  fully  understood.  We  investigated  the
functions  of  miR-451,  which  was  identiﬁed  as  a target  gene  in  the  inﬂammatory  process  in NAFLD.
miR-451  expression  was  signiﬁcantly  decreased  in the  palmitate  (PA)-exposed  HepG2  cells  and  in  liver
tissues  of  HFD-induced  non-alcoholic  steatohepatitis  (NASH)  mice.  Its  decreased  expressions  were  also
observed  in  liver  specimens  of  NASH  patients.  In  vitro  analysis  of  the  effect  of  miR-451  on proinﬂam-
matory  cytokine  provided  evidence  for negative  regulation  of PA-induced  interleukin  (IL)-8  and  tumor
necrosis  factor-alpha  (TNF-)  production.  Furthermore,  miR-451  over-expression  inhibited  translocation
of  the  PA-induced  NF-B  p65  subunit  into  the nucleus.  Our  result  showed  that  Cab39  is  a  direct  target  of
miRNA-451  in  steatotic  cells.  Further  study  showed  that  AMPK  activated  through  Cab39  inhibits  NF-B
transactivation  induced  in steatotic  HepG2  cells.  miR-451  over-expression  in steatotic  cells  signiﬁcantly
suppressed  PA-induced  inﬂammatory  cytokine.  These  results  provide  new insights  into  the  negative
regulation  of  miR-451  in fatty  acid-induced  inﬂammation  via  the  AMPK/AKT  pathway  and  demonstrate
potential  therapeutic  applications  for miR-451  in  preventing  the  progression  from  simple  steatosis  to
severely  advanced  liver  diseas
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. Introduction
Non-alcoholic fatty liver disease (NAFLD) with accumulated fat
n the liver is a common cause of chronic liver disease in Western
ountries (Lewis and Mohanty, 2010; Ogawa et al., 2014). NAFLD
omprises a diverse spectrum of manifestations, ranging from sim-
le steatosis to steatohepatitis, ﬁbrosis and cirrhosis (Nguyen and
anyal, 2012). A subset of individuals with NAFLD progress to
ecompensated liver diseases and liver cancer (Pais et al., 2013).
he recent increasing prevalence of NAFLD is considered to be
elated to the epidemic of obesity and type 2 diabetes in the USA and
ther developed countries (Bellentani and Marino, 2009). In addi-
ion, NAFLD is reported to be strongly associated with metabolic
yndrome including hypertension and cardiovascular disease and
t is therefore regarded as a clinical manifestation of complex
etabolic disease spectrum in the liver (Targher et al., 2010). For
his reason, it is necessary to actively investigate the underlying
isease mechanism to manage the individuals with NAFLD more
ffectively.
A “two-hit hypothesis” was initially proposed to explain the
athogenesis and progression of NAFLD (Day and James, 1998).
owever, recent investigations have provided evidence that ‘mul-
iple hits’ of multiple factors are involved in the pathogenesis
nd progression of NAFLD (Tilg and Moschen, 2010). These hits
xecute the occurrence of parallel events of a complex interplay
mong host genetics, environmental risk factors and, the gut micro-
iota (Bechmann et al., 2012). Such interactions can cause isolated
epatic steatosis, innate immune activation, inﬂammation, apo-
tosis and/or progressive liver damage (Tilg and Moschen, 2010).
lthough considerable progress has been made recently in elu-
idating the pathogenesis of NAFLD, it remains unclear how the
nﬂammatory mediators are involved in the progression of NAFLD.
o investigate the molecular mechanisms underlying the progres-
ion of NAFLD, it is essential to develop appropriate in vitro and
n vivo models. We  previously established a high fat diet (HFD)-
nduced NAFLD mouse model that exhibits pathological features
imilar to those in humans (Kim et al., 2014). In addition, we devel-
ped an in vitro model of hepatocytic steatosis in a HepG2 cell line
xposed to palmitate (PA). We  also showed the preventive and ther-
peutic effects of oleuropein, a secoiridoid derived from olives (Olea
uropaea), on the progression of hepatic ﬁbrosis from steatohepati-
is in these experimental models (Hur et al., 2012; Kim et al., 2014;
ark et al., 2011).
MicroRNAs (miRNAs) represent a class of small non-coding
NAs involved in various biological processes, including cell prolif-
ration, development and differentiation (Shukla et al., 2011).
Recent studies have demonstrated that miRNAs play important
oles in the control of energy, and hepatic metabolic functions
egulating fatty acid (FA) and cholesterol metabolism in NAFLD
Alisi et al., 2011; Ceccarelli et al., 2013). Of the many differentially
xpressed miRNAs between steatosis and nonalcoholic steatohep-
titis (NASH), we focused miRNA (miR)-451 and studied the role of
iR-451 in the progression of NAFLD to NASH.
miR-451 is known to exert various biological functions in cancer,
nfectious disease, cardiovascular and metabolic diseases. Previous
tudies have revealed that the dysregulation of miR-451 expres-
ion is involved in carcinogenesis and in tumor progression by
ffecting cell proliferation, cell-cycle distribution, migration, and
nvasion (Li et al., 2013; Liu et al., 2013; Tian et al., 2012). Fur-
hermore, a recent study showed that miR-451 regulates dendritic
ell cytokines and suppresses neutrophil chemotaxis via down-
egulation of p38 MAPK phosphorylation (Murata et al., 2014;
osenberger et al., 2012). Speciﬁcally, the effects of miR-451 are
ediated by the liver kinase B1 (LKB1)/5′-adenosine monophos-
hate activated protein kinase (AMPK) pathway, which controls
ey players in metabolic pathways and thus emerges as a majoremistry & Cell Biology 64 (2015) 265–276
regulator of glucose and lipid metabolism with multiple beneﬁcial
roles in the target tissues (Godlewski et al., 2010). However, the
expression and function of miR-451 in NAFLD are still unclear and
the molecular mechanisms underlying the progression to NASH
from simple steatosis have yet to be elucidated. Our study aimed to
investigate the role of miR-451 in the molecular mechanisms of the
pathogenic procession of NAFLD. We found that miR-451 expres-
sion was downregulated in the livers of HFD-induced NASH mice
and that miR-451 regulates inﬂammatory cytokine secretion from
steatotic cells through the AMPK, Akt and NF-B singling pathways
via direct targeting of Cab39.
2. Materials and methods
2.1. Animals and diets
Five-week-old male C57BL/6 mice were purchased from Orient
Bio (Seoul, South Korea) and housed in a standard animal facility
under a 12:12-h light–dark cycle with a constant room tempera-
ture. The mice were divided into four weight-matched groups. Mice
were fed either a normal diet (ND) of 3.8 kcal/g (ND; 50.21% carbo-
hydrate, 20.78% protein and 4.8% fat) or high fat diet (HFD: D12231,
Research Diets, Inc., New Brunswick, NJ) of overall 5.2 kcal/g (25.5%
carbohydrate, 16.4% protein and 58% fat) for 3 months or 9 months
ad libitum. Food intake was measured by weighing the pellets once
per week. All animals were cared for according to institutional
guidelines, and all experiments were approved by the Institutional
Animal Care and Use Committee at the Catholic University of Korea.
In all experiments, each group consisted of at least 3–4 mice.
2.2. Hepatic pathological evaluation
Fresh liver tissue samples were ﬁxed in 3.7% buffered formalin,
and then embedded in parafﬁn wax. Liver pathology was assessed
by hematoxylin-eosin (H&E) and Oil Red O staining of liver sec-
tions for evaluation of steatosis, fat droplets and inﬂammation. All
stained slides were scored by two experienced pathologists and
graded by a previously described classiﬁcation (Jeen and Jin, 2009).
The degree of steatosis was graded on a four-point scale: grade
0, steatosis in <5% of hepatocytes; grade 1, steatosis in up to 33%;
grade 2, steatosis in 33–66%; grade 3, steatosis in >66% of hepato-
cytes. Lobular inﬂammation was also graded on a four-point scale:
grade 0, no foci; grade 1, fewer than two  foci per 20× ﬁeld; grade 2,
two to four foci per 20× ﬁeld; grade 3, more than four foci per 20×
ﬁeld. Hepatocyte ballooning was graded on a three-point scale: 0,
none; 1, a few balloon cells; 2, many/prominent balloon cells. For
the NAFLD activity score (NAS), features of steatosis, lobular inﬂam-
mation, and hepatocyte ballooning were combined, and the range
was scored from 0 to 8. Cases scoring ≥5.0 were diagnosed as NASH,
while cases ≤2 were diagnosed as simple steatosis.
2.3. mRNA microarray experiments
Total RNAs were prepared independently from liver tissues of
two different mice for each condition (3 month-HFD, 9 month-HFD
and control) using the RNeasy mini kit (Qiagen, Hilden, Germany).
RNA integrity was  assessed using an Agilent 2100 Bioanalyzer.
RNA integrity numbers for all samples were above 8.5. RNA was
then reverse-transcribed, ampliﬁed and hybridized to the Agilent
SurePrint G3 mouse GE 8X60K microarray according to the Agilent’sG2565BA microarray scanner and normalized using the quantile
normalization method (Bolstad et al., 2003). The microarray data
were deposited in the gene expression omnibus (GEO) database
(accession ID: GSE59042).
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.4. Statistical analysis of gene expression data
Comparisons (control versus 3 month-HFD and control versus
 month-HFD) were conducted to identify differentially expressed
enes (DEGs) using the integrative statistical method previously
eported (Chae et al., 2013). Brieﬂy, for each mRNA, an adjusted
-value was computed by performing the two-tailed T-test and
og2 median ratio test using the empirical distributions estimated
y random permutations of the samples. The two  sets of P-values
rom the individual tests were combined to compute the overall
-values using Stouffer’s method (Hwang et al., 2005). Finally, the
EGs were selected for genes with (1) P ≤ 0.05 and (2) absolute
og2-fold-changes ≥0.58 (1.5-fold). Enriched GO biological process
enes were identiﬁed as the ones with P < 0.05 using DAVID soft-
are (Huang da et al., 2009).
.5. Quantitative real-time reverse transcriptase-polymerase
hain reaction (qRT-PCR)
Total RNA was isolated from pooled mouse livers in each group
sing the RNeasy Plus Mini kit (Qiagen). MicroRNA was prepared
s described above. The qRT-PCR for miRNAs was  performed using
he Mir-XTM miRNA First-Strand Synthesis Kit and SYBR Advan-
age qPCR Premix (Clontech, Mountain View, CA) on an Applied
iosystem 7500 Fast system (Applied Biosystems) according to the
anufacturer’s instructions. Relative expression of each miRNA
as normalized to the U6 snRNA (CT) in each sample. Quanti-
ative expression of a given miRNA was compared to the internal
ontrol and determined according to the CT method (2−Ct) (Livak
nd Schmittgen, 2001).
.6. Cell culture and siRNA/miRNA transfection
HepG2 cells (American Type Culture Collection, Manassas, VA)
ere grown in minimum essential medium (MEM;  Invitrogen,
arlsbad, CA) supplemented with 10% fetal bovine serum (FBS),
00 g/ml penicillin, and 0.25 g/ml streptomycin at 37 ◦C in a
umidiﬁed incubator with 5% CO2. Fatty acid-free bovine serum
lbumin (1%; Sigma–Aldrich, St. Louis, MO)  was used as a vehicle
or PA treatment. After reaching 70% conﬂuence, cultured cells were
erum-starved and exposed to 0.5 mM PA in medium containing 1%
FA-free BSA.
Cells were transfected with hsa-miR-451mimic (Genolution
harmaceuticals, Seoul, Korea), Cab39 siRNA, or scrambled miRNA
Genolution) as a negative control using G-fectin (Genolution)
ccording to the manufacturer’s instructions at a ﬁnal concentra-
ion of 30 nM.  All transfections were carried out in duplicate or
riplicate.
.7. Immunoprecipitation and western blot analysis
Immunoprecipitation was performed as previously described
Godlewski et al., 2010). Following treatment, cells were washed
nd lysed in protein extraction buffer containing 20 mM Tris (pH
.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 2 mM EDTA, 1 mM
henylmethylsulfonyl ﬂuoride, and Complete Protease Inhibitor
ocktail (Roche, Mannheim, Germany). Lysates were cleared by
entrifugation, and the protein content was determined using a
radford protein assay kit (Bio-Rad, Hercules, CA). Cell lysates
ere separated by 12% SDS-polyacrylamide gel electrophoresis and
ransferred to nitrocellulose membranes (Whatman, Maidstone,
ent, UK). The membranes were incubated overnight at 4 ◦C with
he following primary antibodies against -actin, Cab39/MO25,
MPK, phospho-AMPK, p65 (RelA), phospho-IB, STRAD, LKB1,
GT, or Ywhaz. After overnight incubation, membranes were
ashed three times with Tris-buffered saline containing 0.05%
ween-20 and incubated with horseradish peroxidase-conjugatedemistry & Cell Biology 64 (2015) 265–276 267
anti-mouse, anti-rabbit or anti-goat secondary antibodies (Amer-
sham Pharmacia Biotech, Piscataway, NJ). Protein bands were
visualized using an enhanced chemiluminescence system (Amer-
sham Pharmacia Biotech) according to the manufacturer’s
instructions. Protein band densities were determined by densit-
ometry analysis (NIH Image J software, Bethesda, MA).
2.8. Cell fractionation and immunoﬂuorescence staining
Transfected HepG2 cells were fractionated into nuclear fractions
using a NE-PER kit (Pierce, Rockford, IL).
For immunoﬂuorescence staining, transfected cells were ﬁxed,
incubated with anti- NF-B p65 mouse monoclonal (Cell Signaling)
antibodies, followed by incubation with Alexa 594-labeled anti-
mouse IgG (1:500; Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA). Cells were stained with DAPI (Sigma) to counter-
stain the nuclei and then examined using ﬂuorescence microscopy
(Carl Zeiss, Oberkochen, Germany).
2.9. Luciferase reporter assays
Cells (5 × 105/well) were seeded in triplicate wells in six well
plates. One hundred nanograms of pNF-B luciferase plasmid or
pGL3 luciferase plasmid (control-luciferase plasmid) plus 10 ng
pRL-TK Renilla plasmid (Promega, Madison, WI)  were transfected
into cells using the Lipofectamine 2000 reagent (Invitrogen). Two
days after transfection, the luciferase activity was measured using
the Dual Luciferase Reporter Assay Kit (Promega) according to
the manufacturer’s protocol. The ﬁreﬂy luminescence signal was
normalized to the Renilla luminescence signal. Three indepen-
dent experiments were performed and data are presented as the
mean ± SD.
2.10. Quantitation of cytokine concentration in supernatants
from cultured cells using ELISA
The transfected HepG2 cells were grown in triplicates and
stimulated with 0.5 mM PA in MEM  containing 1% FFA-free BSA.
Conditioned medium was saved and stored at −70 ◦C until use. The
amount of IL-8 and TNF- released into culture supernatants was
quantiﬁed by using a human IL-8 and TNF- Quantikine ELISA Kit
according to the manufacturer’s instructions (R&D Systems, Min-
neapolis, MN). The absorbance at 450 nm was  determined on an
ELISA reader (Laboratory systems, iEMS Reader MF,  Copenhagen,
Denmark).
2.11. Statistical analysis
All data are represented as means ± standard error of at least
three separate experiments. The Student’s t-test for unpaired two
groups was executed using SPSS (IBM, New York). Differences were
considered statistically signiﬁcant at P < 0.05 or P < 0.001.
3. Results
3.1. Alteration of inﬂammation-related gene expression in the
livers of HFD-induced NAFLD mice
Mechanisms associated with the progression of simple steatosis
to steatohepatitis in NAFLD remain undeﬁned. Understanding the
molecular mechanisms underlying the process of NAFLD is essen-
tial in designing rational treatment strategies.First, to determine how gene expression is altered between
NAFLD and NASH, we performed the gene expression proﬁles in
liver tissues from HFD-induced NAFLD mice compared to those
from ND-fed mice using Agilent SurePrint G3 mouse microarray
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latforms. The NAFLD mouse model was established successfully
fter feeding a 58% HFD for 3 months (NAFLD) and 9 months (NASH)
nd conﬁrmed by an independent pathologist. Our treatment result
as consistent with previous reports (Kim et al., 2014). This was
etermined by H&E (Fig. 1A) and Oil Red O (Fig. 1C) staining, which
evealed that simple steatosis occurred at 3 months with various
egrees of fat deposition. At 9 months, the disease progressed to
ASH with more severe steatosis, numerous ballooning hepato-
ytes and mild to moderate lobular inﬂammation (Fig. 1B).
To identify potential molecular pathways involved in NAFLD
rogression, we then compared mRNA expression levels in HFD-
nduced NAFLD mice (3 or 9 months) compared to those in ND-fed
ice. We  identiﬁed a total of 2362 DEGs (with 1485 and 1597 at
 and 9 months, respectively) using a previously reported statis-
ical method (Section 2). Based on the differential expression of
hose genes, 2362 DEGs were further categorized into eight clusters
Supplementary Table S1). We  focused on six major clusters (C1–6;
ig. 1D) with more than 118 genes (5% of the total number of DEGs).
o understand the cellular processes represented by the genes in
ndividual clusters, we performed an enrichment analysis of Gene
ntology biological processes (GOBPs) for the genes in each cluster
Fig. 1E right). The early up-regulated genes at 3 months (C1–2) are
ainly involved in processes related to innate immune response
antigen processing and presentation, cell adhesion, leukocyte
ifferentiation, cell proliferation, and lipid transport), indicating
arly activation of these immune processes. Some of these pro-
esses (antigen processing and presentation, cell adhesion and
ipid transport), represented by C1, showed sustained activations
t 9 months, while others, represented by C2, were restored
ack to basal levels. Importantly, the late up-regulated genes at
 months (C3) are involved in other inﬂammation related pro-
esses (blood coagulation, lipid synthesis and metabolic processes,
egulation of angiogenesis, ion homeostasis, and cell migration),
ndicating severe and systematic inﬂammation. In contrast, the
own-regulated genes are involved in processes in oxidative stress
esponse, translation and cell proliferation.
Taken together, these results show that hepatic inﬂammation is
ne of the most distinguishing features of NASH and therefore more
etailed insight in inﬂammation related processes in the progres-
ion of NAFLD is needed.
.2. Expression of miR-451 is down-regulated in human NASH
The results of microarray analysis revealed that one of the genes
ifferentially expressed between NAFLD and NASH is miR-451,
hich is known to be involved in cytokine production, cancer,
nfectious diseases, cardiovascular and metabolic diseases. To fur-
her determine the potential roles of miR-451 in the progression
f NAFLD, we measured its hepatic expression in liver tissues in
ouse models and human specimens with histologically conﬁrmed
AFLD and NASH, respectively, by stem-loop RT-PCR. As shown in
ig. 2A, the levels of miR-451 were signiﬁcantly decreased in the
ivers of HFD-induced NASH mice (at 9 months) compared with
hose in HFD-induced hepatic steatotic mice (at 3 months). Our
esults showed that the expression levels of miR-34a were sig-
iﬁcantly higher in NASH than simple steatosis (Fig. 2B). These
esults are consistent with the previous results (Castro et al., 2013,
ogribny et al., 2010), thus validating that our HFD-induced NAFLD
nd NASH models were appropriate for further characterization.
e  also examined the levels of miR-451 in human liver sections
ith NAFLD or NASH. Interestingly, the expression levels of miR-
51 were signiﬁcantly decreased in patients with NASH compared
o simple steatosis (Fig. 2C).
These results suggest that miR-451 expression was  down-
egulated in the inﬂammatory progression of NAFLD in both animal
odels and human specimens.emistry & Cell Biology 64 (2015) 265–276
3.3. miR-451 inhibits palmitate induced production of
proinﬂammatory cytokines
A previous study showed that miR-451 regulated the produc-
tion of cytokines by inﬂuenza-infected dendritic cells (Rosenberger
et al., 2012). Based on this result, we examined the effect of miR-451
expression on pro-inﬂammatory cytokine production to deter-
mine whether miR-451 plays a role in regulating production of
inﬂammatory cytokines partly responsible for the progression from
simple steatosis to NASH. We  ﬁrst established a model of cellular
steatosis by incubating HepG2 cells with PA in media containing
FFA-free BSA (Fig. 2D) and measured the production of proinﬂam-
matory Cytokines, such as IL-8 and TNF- as previously reported
(Joshi-Barve et al., 2007; Manco et al., 2007).
As shown in Fig. 2E, miR-451 expression was signiﬁcantly lower
in HepG2 cells treated with PA than in cells treated with BSA alone.
In addition, the expression level of miR-451 was  signiﬁcantly higher
in HepG2 cells harboring ectopically expressed miR-451 than in the
scrambled miRNA-transfected cells (miR-NC) (P < 0.05, Fig. 2F).
We next examined whether PA-induced secretion of IL-8
and TNF- is negatively affected by miR-451 mimics. The ELISA
result showed that PA-induced IL-8 and TNF- expression was
signiﬁcantly decreased in miR-451-overexpressing HepG2 cells
compared with miR-NC-transfected cells (Fig. 2G). However, IL-
8 and TNF- expression was  not signiﬁcantly different between
miR-451-overexpressing HepG2 cells and miR-NC-transfected cells
following treatment with BSA (Fig. 2G). These ﬁndings indicate that
miRNA-451 expression can negatively regulate pro-inﬂammatory
cytokine expressions in PA-exposed HepG2 cells.
Taken together, our results further demonstrate that miR-451
could modulate inﬂammatory cytokine production in the progres-
sion of NASH from simple steatosis.
3.4. miR-451 expression inhibits PA- induced NF-B activation
Since IL-8 or TNFa expression activated by PA can be modulated
by NF-kB as reported (Joshi-Barve et al., 2007; Wang et al., 2009), we
further investigated whether miR-451 expression might modulate
NF-kB activation in PA-exposed HepG2 cells. To this purpose, we  co-
transfected with luciferase-reporter constructs containing NF-kB
binding motifs and miR-451 mimics into HepG2 cells. As expected,
the expression of miR-451 mimicked signiﬁcantly reduced PA-
induced luciferase activity indicating an attenuation of NF-B
activation in PA-exposed HepG2 cells (Fig. 3A). However, there was
no signiﬁcant difference in luciferase activity between both groups
of HepG2 cells treated with BSA alone.
Since NF-B activation is usually mediated by the nuclear
translocation of the NF-B/Rel family of transcription factors, we
examined the effect of miR-451 overexpression on the cytosolic and
nuclear distribution of the NF-B p65 subunit by Western blot anal-
ysis after transfection and PA or BSA treatment (Fig. 3B). We  showed
that PA treatment effectively increased the nuclear NF-B p65 pro-
tein level and decreased the cytosolic NF-B p65 protein level,
which is an indication of the nuclear translocation of NF-B p65
subunit. However, ectopic overexpression of miR-451 inhibited the
PA-stimulated increase and decrease of the nuclear and cytosolic
NF-B p65 levels in HepG2 cells. We further determined whether
miR-451 expression had any effect on IB- phosphorylation in PA-
exposed HepG2 cells. As shown in Fig. 3C, PA treatment in HepG2
cell induced IB- phosphorylation and miR-451 expression in PA
exposed cell inhibited PA-induced IB- phosphorylation.
An immunoﬂuorescent staining analysis after PA treatment
showed that the red ﬂuorescence intensity from positive NF-B p65
antibody staining in the nucleus was  decreased in miR-451 over-
expressing HepG2 cells compared with miR-NC transfected HepG2
cells (Fig. 3D and E). However, there was no signiﬁcant difference
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Fig. 1. Alteration of inﬂammation-related gene expression in the livers of HFD-induced NAFLD mice. (A) Representative H&E staining of hepatic sections (×400 object, scale
bar  = 25 m). Livers from mice fed a normal diet (chow, n = 8) or HFD for 3 months (steatosis, n = 4) or 9 months (NASH, n = 9). The liver sections from mice fed HFD for 9
months  (NASH) show deposition of large fat droplets (LD), inﬁltration of inﬂammatory cells (black box) and hepatocyte necrosis. Normal histology of liver sections is seen
from  mice fed on a normal diet. (B) The inﬂammation score of the mouse liver specimens is described in the “Materials and methods” section. *P < 0.05 compared with 3 MO
HFD.  (C) Representative Oil red O staining for lipids in the livers of C57BL/6 mice fed a chow or HFD, as indicated (×150 object, Scale bar = 100 m).  (D) Heat map showing the
six  major clusters of the DEGs (C1–6). Red and green colors represent up- and down-regulation in HFD, respectively, compared to control. Numbers of the genes in clusters
are  denoted in parentheses. Color bar, gradient of log2-fold-changes. (E) Heat map  showing the GOBPs represented by genes in C1–6. The color represents the signiﬁcance
(P-value) of the GOBPs being represented by the genes in C1–6. Color bar, gradient of −log2(P), where P is the P-value computed using DAVID software. (For interpretation
of  the references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
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Fig. 2. Down-regulation of miR-451 expression negatively regulates IL-8 expression in HepG2 cells treated with PA. (A, B) miR-451 (A) and miR-34a (B) expression in liver
tissue  was  measured from C57BL/6 mice fed with a normal diet (n = 8) or HFD for 3 months (n = 4) or 9 months (n = 9) by qRT-PCR. *P < 0.05, **P < 0.001 compared with 3
MO  HFD. (C) Determination of miR-451 expression by qRT-PCR in biopsied livers of NASH patients (n = 4) compared to those with steatosis (n = 3). *P < 0.05 compared with
steatosis. (D) Representative ﬂuorescence photomicrographs showing intracellular lipid accumulation in Nile Red-stained cells after transfection with miR-451 mimics in the
presence of 0.5 mM PA. The nuclei were counterstained with DAPI (blue). Scale bar = 25 m. (E) The miR-451 expression levels in cultured HepG2 cells treated with BSA or PA
were  determined by using qRT-PCR. *P < 0.05 compared with BSA alone. (F) HepG2 cells were transfected with 30 nM of miR-NC or miR-451 mimics for 24 h. qRT-PCR analysis
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A-induced IL-8 and TNF- secretion. miR-451 expressing HepG2 cells were treated
y  ELISA. *P < 0.05 compared from miR-NC. (For interpretation of the references to c
n positive NF-B p65 antibody staining between both groups after
SA treatment. The results suggest that miR-451 overexpression
egulates NF-kappaB pathway through inhibition of nuclear NF-B
65 translocation via IB- phosphorylation
.5. miR-451 is a repressor of Cab39 translation
Previous studies have demonstrated that miR-451 targets the
′UTR mRNAs of Cab39 (Godlewski et al., 2010; Tian et al., 2012),
GT (Bergamaschi and Katzenellenbogen, 2012) and Ywhaz (Wu
t al., 2013; Zhang et al., 2012) in multiple cell types. To conﬁrm
he expression of these target genes regulated by miR-451, qRT-
CR and Western blotting were performed with murine hepatic
issues. The OGT and Ywhaz protein levels remained unchanged
etween HFD-induced hepatic steatosis (3-months) and NASH
9-months) mice (Supplementary Fig. S1). However, the expression
evels of Cab39 mRNA and protein were increased greater in the
ivers of HFD-induced NASH mice compared to HFD- induced
AFLD (Figs. 4B and C, respectively). Based on these results, we1 cells. *P < 0.05 compared from miR-NC. (G) miR-451 overexpression suppressed
A or BSA as indicated for 12 h followed by IL-8 and TNF- expression measurement
n this ﬁgure legend, the reader is referred to the web version of the article.)
investigated whether miR-451 directly regulates the Cab39 level
in HepG2 cells transfected with miR-451 mimics by qRT-PCR and
Western blot analyses. Our results showed that ectopic overex-
pression of miR-451 signiﬁcantly reduced the expressed levels of
Cab39. However, its expression level was  not changed in miR-NC
transfected cells (p < 0.05, Fig. 4D and E).
Together, these results demonstrated that the target sequence
in the 3′-UTR of Cab39 (Fig. 4A) was regulated by miR-451 and this
regulation could contribute to the negative correlation between
endogenous miR-451 and Cab39 expression during NASH develop-
ment.
3.6. miR-451 inhibits PA-induced inﬂammation through the
LKB1-AMPK pathwayCab39 functions as an armadillo repeat scaffolding-like pro-
tein that promotes LKB1 activity through stabilization of the
LKB1/STRAD/Cab39 complex (Boudeau et al., 2004; Hawley et al.,
2003; Taylor et al., 2006; Zeqiraj et al., 2009). To investigate the
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Fig. 3. Regulation of NF-B signaling by miR-451 expression. (A) HepG2 cells were cotransfected with an NF-B-Luc reporter plasmid or pGL3 luciferase reporter plasmid
(Control-luc) and miR-451 mimics or a negative control pre-miRNA followed by exposure to PA or BSA. The HepG2 cells were also transfected with a vector containing Renilla
luciferase to serve as a transfection efﬁciency control. After 6 h of PA or BSA treatment, cells were lysed and analyzed for luciferase expression using a dual-luciferase assay
system. Results are expressed as the relative luciferase activity to the control vector. *P < 0.05 compared from miR-NC. (B) HepG2 cells were harvested, and then prepared
nuclear, cytosolic and whole cells extracts for the detection of NFB p65 subunit. Western blot analysis shows the expression level of p65 in the nuclei, in the cytoplasm
and  in the whole cell in miR-451 expressing HepG2 cell with PA or BSA for 6 h. Summarized data (n = 3 experiments) show the average protein level of p65 (normalized
to  the protein level of PARP or -tubulin or -actin) corresponding to the bands shown in the Western blots. (C) Phosphorylated IB was assessed in total extracts by
western blot. Results are expressed as ratio of p-IkB-a to -actin. (D) HepG2 cells were stained with polyclonal anti- NF-B p65 antibodies. The detection of NF-B p65 with
Cy3-conjugated secondary antibody (red) shows its distribution in the cytoplasm and nucleus of cells. The nuclei were counterstained with DAPI. An overlay of the images
reveals the localization of NF-B p65 proteins in the nucleus (purple). NF-B p65 was  located in the cytoplasm on miR-451 mimics or a negative control pre-miRNA followed
by  exposure to BSA (white arrow). NF-B p65 translocated to nucleus after stimulated by PA (white arrow). miR-451 overexpression inhibited the translocation of NF-B
p65  into the nucleus after stimulated by PA (white arrow). These were observed by immunoﬂuorescence. Magniﬁcation ×400. Scale bar = 25 m.  (E) Quantiﬁcation of the
effects of miR-451 expression on the translocation of p65. The translocation of p65 in 50–100 cells was analyzed. The percentage of cells with nuclear p65 is indicated, error
bars  represent SD (three experiments with at least 50 cells analyzed/condition and experiment), *P < 0.05. (For interpretation of the references to color in this ﬁgure legend,
the  reader is referred to the web version of the article.)
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Fig. 4. Cab39 is a direct target of miR-451. (A) A conserved 7-mer target seed region (gray) of the miR-451 binding site was  identiﬁed within the 3′ UTR of Cab39 in different
mammalian species. (B) Real time analysis of Cab39 mRNA levels in livers from mice fed either regular chow (n = 4) or HFD for 3 months (n = 4) or 9 months (n = 9). *P < 0.05
compared with 3 MO HFD. (C) Cab39 protein levels in livers from mice fed either regular chow (n = 4) or HFD for 3 months (n = 4) or 9 months (n = 9). *P < 0.05 compared
with  3 MO HFD. (D–E) HepG2 cells were transfected with miR-NC or miR-451 mimics. qRT-PCR (D) and immunoblot analyses (E) were performed 24 h after transfection to
determine the Cab39 mRNA and protein levels, respectively, in transfected HepG2 cells. -Actin was  served as an internal control. *P < 0.05 compared with miR-NC.
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ffect of miR-451 expression on LKB1/STRAD/Cab39 complex for-
ation in HepG2 cells after PA exposure, we immunoprecipitated
KB1, followed by immunoblot analysis for LKB1, STRAD and Cab39.
he overexpression of miR-451 substantially impaired the for-
ation of a trimeric LKB1/STRAD/Cab39 complex in HepG2 cells
ig. 5. Regulation of the LKB1/AMPK/AKT signaling pathway by miR-451 in PA- treated H
KB1  was  immunoprecipitated from the cell homogenates of PA-treated HepG2 cells tra
nti-Cab39 or anti-STRAD antibodies. Input controls were blotted with anti-Cab39, anti-S
as  used as a loading control. Quantiﬁcation of the data shown in immunoprecipitation
iR-NC. (B, C) Effect of miR-451 expression on AMPK phosphorylation and its downstre
KB1,  AMPK, ACC and AKT in miR-451-overexpressing cells after PA or BSA treatment. Ba
o  total AMPK, total ACC, total AKT or -actin expression. *P < 0.05 compared with miR-N
epG2  cells transfected with Cab39 siRNA or a scrambled siRNA.emistry & Cell Biology 64 (2015) 265–276 273
treated with PA compared to BSA alone (Fig. 5A). These results indi-
cate that miR-451 expression modulated the stabilization of the
trimeric LKB1/STRAD/Cab39 in PA-induced steatotic HepG2 cells.
Based on these results, we  hypothesized whether the
effect of miR-451-mediated anti-inﬂammation was related
epG2 cells. (A) Stabilization of the LKB1 complex by Cab39 as a target of miR-451.
nsfected with miR-451 mimics or miR-NC followed by immunoblot analysis with
TRAD, anti-LKB1 antibodies and anti--actin antibody as indicated, while -actin
 intensity was  normalized to LKB1 immunoprecipitation. *P < 0.05 compared with
am pathway. We  performed immunoblot analysis to examine the levels of Cab39,
nd densities were quantiﬁed using TINA imaging analysis software and normalized
C. (D) Western blotting was performed with cell extracts from BSA- or PA-treated
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o the AMPK/AKT pathway through stabilization of the
KB1/STRAD/Cab39 complex. To determine whether miR-451
xpression inhibits PA-induced inﬂammation through blocking
he AMPK/AKT pathway, we performed immunoblot analysis to
easure the levels of Cab39, LKB1, AMPK Thr172 phosphoryla-
ion, ACC Ser79 phosphorylation and AKT Ser473 phosphorylation
n miR-451-overexpressing cells treated with PA. As shown in
ig. 5B, overexpression of miR-451 in HepG2 cells treated with
A decreased LKB1, AMPK Thr172 phosphorylation and ACC Ser79
hosphorylation compared with miR-NC transfected HepG2 cells.
he inhibition of AMPK phosphorylation led to decreased AKT
hosphorylation (Fig. 5C). Similar to miR-451, silencing of Cab39
y the speciﬁc siRNA reduced the levels of AMPK phosphory-
ation and phosphorylated AKT in HepG2 cells treated with PA
Fig. 5D). In contrast, treatment of cells with a negative con-
rol siRNA did not alter the phosphorylation of AMPK and AKT,
upporting the hypothesis of a miR-451-Cab39-AKT pathway.
ollectively, these data demonstrate that miR-451 directly targets
nd down-regulates Cab39, resulting in inhibition of PA-induced
nﬂammation through the AMPK/AKT pathway (Fig. 6).inued)
4. Discussion
NAFLD, one of the most common causes of chronic liver dis-
ease (Lewis and Mohanty, 2010; Ogawa et al., 2014), is the result
of excessive hepatic fat accumulation. The current understand-
ing of the development and progression of NAFLD is encapsulated
by a multistep process associated with hepatic steatosis, innate
immune activation, inﬂammation, apoptosis and progressive liver
damage. Our previous studies have shown that a mouse model
of NAFLD, which was  successfully established in C57BL/6 mice by
HFD feeding exhibited morbid obesity with increased liver dam-
age and collagen accumulation over time (Kim et al., 2014). In this
study, the systematic investigation of cDNA expression proﬁling
between hepatic steatosis and NASH was  performed to explore
the cellular mechanisms in the development of NASH. Among
the signiﬁcantly differentially expressed pathways, we  focused
on the roles of miR-451 during progression to NASH from sim-
ple steatosis. Consistent with a previous report (Alisi et al., 2011),
our results showed that miR-451 expression was down-regulated
in HFD-induced NASH mice (Fig. 2A) in liver tissue from human
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aig. 6. Schematic diagram to show new negative regulation of miR-451 in the mod-
lation of IL-8 expression during the progression of NAFLD via the AMPK/AKT/NF-
B pathway.
atients with NASH compared to those from patients with sim-
le steatosis (Fig. 2C). These ﬁndings suggested that miR-451 plays
n important role in the pathophysiological mechanisms involved
he progression of NAFLD. Previously, many research groups have
lso demonstrated different biological functions for miR-451 in car-
inogenesis and tumor progression by affecting cell proliferation,
ell-cycle distribution, migration, and invasion (Bergamaschi and
atzenellenbogen, 2012; Gal et al., 2008; Li et al., 2013; Liu et al.,
013; Tian et al., 2012). In this study, we identiﬁed miR-451 as a
AFLD-expressed miRNA that regulates the production of inﬂam-
atory cytokines.
Among these proinﬂammatory cytokines, IL-8 functions as a
ritical chemoattractant and activator for neutrophils, basophils
nd T cells (Koch et al., 1992; Strieter et al., 1995). Many studies
ave shown that increased IL-8 expression is associated with sev-
ral diseases, including NASH, obesity, diabetes, atherosclerosis,
nd various forms of liver injury (Kumar et al., 2012). More-
ver, serum and hepatic levels of TNF- in patient with NASH
re increased and TNF- levels correlate with histological severity
Dowman et al., 2010; Manco et al., 2007). These results suggest that
roinﬂammatory cytokines, such as IL-8 or TNF- play a key role in
he development and/or progression of such metabolic diseases by
romoting inﬂammation and tissue injury. In study, we employed
n in vitro model of hepatic steatosis to investigate the molecularemistry & Cell Biology 64 (2015) 265–276 275
mechanisms linked to inﬂammatory processes associated with IL-8
and TNF levels. We  demonstrated that IL-8 and TNF levels were
signiﬁcantly increased in HepG2 cells treated with free fatty acid
PA. This suggests that IL-8 and TNF expression induced by free
fatty acid may  play an important role in inﬂammatory liver injury
and the progression of NAFLD. Furthermore, we demonstrated that
NASH patients have signiﬁcantly higher serum IL-8 and TNF lev-
els than healthy control group, suggesting an important role for
IL-8 and TNF in the pathogenesis of NASH (Supplementary Fig.
S2). However, these IL-8 and TNF expressions was  signiﬁcantly
decreased in HepG2 cells treated with miR-451 mimics suggesting
that miRNA-451 expression could negatively regulate inﬂamma-
tory cytokine expressions in PA-exposed HepG2 cells. In this regard
miR-451 may  be a promising target molecule preventing the pro-
gression of NAFLD. Therefore, we  further investigated the role and
the molecular mechanism by which miR-451 promote the devel-
opment of NASH from NAFLD. Our results showed that miR-451
regulates LKB1 activity through direct targeting of Cab39, a com-
ponent of the active LKB1/STRAD/Cab39 complex. Disruption of
LKB1 signaling by constitutive miR-451 expression alters the path-
ways downstream of LKB1 in steatotic cells. In addition, our results
showed a reduced phosphorylation of AMPK and AKT in accordance
with the decreased activation of NF-kB in response to PA treatment.
These ﬁndings suggest that miR-451 plays an important role in the
AMPK/AKT pathway during the progression of NAFLD. The partial
Cab39 knockdown caused by miR-451 treatment led to marked
destabilization of the LKB1/STRAD/CAB39 complex, as shown by
co-immunoprecipitation results. These ﬁndings indicate that miR-
451 overexpression is likely to have a potential inhibitory effect on
the LKB1/AMPK/AKT signaling in steatotic cells (Fig. 6).
Our results offer new insight into the negative regulation of miR-
451 in fatty acid-induced inﬂammation via the AMPK/AKT pathway
and provide potential therapeutic applications for miR-451 in pre-
venting the progression from simple steatosis to severe clinical liver
disease.
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